RBM15 protein disrupts liver function by degrading MCM3 mRNA, impacting mitochondria and fat metabolism.
Researchers have identified that the RBM15 protein plays a crucial role in impairing hepatic mitochondria and beta-oxidation. This disruption occurs through a mechanism involving the m6A modification of MCM3 mRNA, leading to its degradation. MCM3 is essential for cell proliferation and mitochondrial function. The study found that RBM15 binds to MCM3 mRNA in an m6A-dependent manner, promoting its destabilization and subsequent breakdown. This process results in reduced levels of MCM3 protein within liver cells. Consequently, the impairment of MCM3 leads to significant defects in mitochondrial respiration and a decrease in the liver's capacity for beta-oxidation, a key pathway for fatty acid metabolism. The findings highlight RBM15 as a critical regulator of liver metabolic health and suggest potential therapeutic targets for metabolic disorders.
This research elucidates a molecular mechanism by which RBM15 influences liver metabolism through mRNA regulation. The m6A modification pathway, previously known for its role in gene expression, is shown here to directly impact metabolic processes by controlling the stability of key proteins like MCM3. Understanding this regulatory axis could inform strategies for metabolic disease management by targeting RBM15 or related m6A machinery. Future research might explore the systemic implications of RBM15 dysregulation and its potential links to conditions like non-alcoholic fatty liver disease (NAFLD) or other metabolic syndromes, considering the broad impact of mitochondrial function and beta-oxidation on overall health.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.